Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 65Terminated 27Recruiting 25Active not recruiting 13Unknown 10Withdrawn 3Not yet recruiting 2Suspended 1Approved for marketing 1

Sponsor Class

OTHER 7OTHER_GOV 6INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 76Breast Neoplasms 53Colorectal Neoplasms 51Neoplasms 38Advanced Solid Tumors 34Multiple Myeloma 32Prostatic Neoplasms 31Ovarian Neoplasms 28Neoplasm Metastasis 28Recurrence 27Lung Neoplasms 27Carcinoma, Hepatocellular 27Pancreatic Neoplasms 26Advanced Solid Tumor 22Small Cell Lung Carcinoma 20Leukemia, Myeloid, Acute 20Endometrial Neoplasms 19Melanoma 18Triple Negative Breast Neoplasms 16Squamous Cell Carcinoma of Head and Neck 14Lymphoma, Follicular 14Stomach Neoplasms 13Lymphoma, B-Cell 13Glioma 13Glioblastoma 13Uterine Cervical Neoplasms 12Lymphoma 11Head and Neck Neoplasms 11Solid Tumor 10Myasthenia Gravis 9

Interventions

liposomal doxorubicin 1Topotecan 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × INDUSTRY × Carcinoma, Ovarian Epithelial × Clear all
NCT07545460 2026-04-22

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
404 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06748872 2024-12-27

EPITOME-1015-I

Medigene AG

Phase 1 Not yet recruiting
55 enrolled
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡